WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Close this folderScabicides and pediculicides
View the documentBenzyl benzoate
View the documentLindane
View the documentPermethrin
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Benzyl benzoate

Lotion, 25%

General information

Benzyl benzoate is a synthetic compound that is produced from benzoic acid and benzyl alcohol. It is toxic to the ectoparasites Sarcoptes scabiei hominis, Pediculus humanus capitis, P. humanus corporis and Pthirus pubis.

Clinical information

Uses

Treatment of scabies and pediculosis of the head, body and pubic area.

Dosage and administration

All doses are suitable for adults and children.

Scabies:

The lotion should be applied to all skin surfaces, from the scalp to the soles of the feet. Care should be taken to avoid contact with the eyes. It is not necessary to bathe before application. To prevent reinfestation, clothing and bedding should be washed or left outside exposed to the air for 72 hours. The lotion is usually applied once daily at night on 2 consecutive days. This may be followed by a single application at night 3 days later.

All members of the household should be treated simultaneously.

Pediculosis:

The lotion should be applied to the affected area and left for 24 hours before being rinsed off. If necessary, treatment may be repeated after 7 and 14 days.

Contacts should also be treated at the some time.

Contraindications

Known hypersensitivity to benzyl benzoate.

Precautions

Benzyl benzoate should not be applied to acutely inflamed or broken skin.

Use in pregnancy

Benzyl benzoate may be applied safely during pregnancy.

Adverse effects

Irritation of the skin with burning or stinging sensations is common.

Overdosage

Gastric lavage may be of value if undertaken within a few hours of accidental ingestion. If convulsions occur they should be treated with intravenous diazepam. Treatment is otherwise supportive.

Storage

Lotion should be stored in well-closed containers, protected from light.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018